The page is the record's research on the issuer — no analyst, no rating, no view.

NEUROTECH INTERNATIONAL LIMITED (NTI) — research page

AU · au-cm-kg/ASX/NTI · as of 2026-11-06

Identity and listing

NEUROTECH INTERNATIONAL LIMITED is listed on the ASX under ticker NTI, with ISIN AU000000NTI9. The LEI is not on the record, as the ISIN is not in the GLEIF ISIN-to-LEI mapping file. Its security type is Corporate, its segment is not on the record, its sector is Health Care, and its jurisdiction is Australia (ASIC-registered public company). The record holds its status as listed, not halted.

fieldvaluesource · read date
nameNEUROTECH INTERNATIONAL LIMITEDsource · 2026-11-06
exchangeASXsource · 2026-11-06
tickerNTIsource · 2026-11-06
ISINAU000000NTI9source · 2026-11-06
LEInot on the record
security typeCorporatesource · 2026-11-06
segmentnot on the record
sectorHealth Caresource · 2026-11-06
jurisdictionAustralia (ASIC-registered public company)source · 2026-11-06
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 68 filings in the window from 2025-11-06 to 2026-11-06, across 46 filing days. The median gap between filing days is 5 days. The latest filing is dated 2026-11-06 and is of type director_interest, and the latency from the latest filing to the record date is 0 days. The ASX median cadence gap is 6 days, the ASX median filings count is 58, and the ASX median latency is 4.0 days. The Health Care sector median cadence gap is 5.0 days, the sector median filings count is 65, and the sector median latency is 7 days. The issuer's filings are 10 below the ASX median and 3 below the Health Care median.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer6850
exchange median: ASX (1829 issuers)5864
sector median: Health Care (163 issuers)6557
datetypecategoryfiling
2026-11-06director_interestFinal Director's Interest Notice
2026-11-05agm_record_dateResults of Meeting
2026-10-28quarterlyQuarterly Activities/Appendix 4C Cash Flow Report
2026-10-26newswire_releaseNeurotech Reports Announces Allan May and Walter ...
2026-10-26newswire_releaseHealthcare Triangle Enters Neurotechnology AI Devices and Solutions for Southeast Asia

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is BDO Audit Pty Ltd, with its location not on the record. Auditor changes are not on the record, as the market's record does not carry them.

Events and halts

The lifecycle lines of listing, delisting, name change, domicile change and segment move are not on the record, as no lifecycle type map exists for this register yet. The halt flag is listed, not halted.

Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/au/ddo-design-and-distribution-obligations/r1, and the chapter is as of 2026-11-04.

rule acm-68000/au/ddo-design-and-distribution-obligations/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The record holds no research houses named on the issuer's investor-relations page, as none was found on the pages read.

Open research

The record holds 2 openly published research notes: one by RaaS Advisory dated 2022-09-09, and one by Bioshares dated 2021-10-06.

datepublishernotekind
2022-09-09RaaS AdvisoryNeurotech International Ltdissuer-sponsored
2021-10-06BiosharesNeurotech International Phase I/II Autism Results Due this Quarterindependent

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began is not on the record.

Sources

10 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.asx.com.au/markets/trade-our-cash-market/directory (identity.exchange)
10.2
https://www.asx.com.au/markets/company/NTI (identity.isin)
10.3
https://data.gov.au/data/dataset/asic-companies (identity.jurisdiction)
10.4
https://mcp.au-cm-kg.ai/events/ASX/NTI (the disclosure lines)
10.5
https://asx.api.markitdigital.com/asx-research/1.0/markets/announcements ; https://www.nsx.com.au/marketdata/delisted-suspended/ (the halt flag)
10.6
https://announcements.asx.com.au/asxpdf/20260826/pdf/0738gf134q4b9g.pdf (the auditor)
10.7
https://mcp.au-cm-kg.ai/book/aio.json (the orderability chapter)
10.8
https://neurotechinternational.com/wp-content/uploads/NTI-Neurotech-International-ASX-SMID-RaaS-Report-2022-09-09.pdf (open research)
10.9
https://neurotechinternational.com/wp-content/uploads/Bioshares-903-NTI-extract.pdf (open research)
10.10
https://mcp.au-cm-kg.ai/record/ASX/NTI (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"AU000000NTI9"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:9bafddf45986d570.